Inission (INISS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
23 Jan, 2026Executive summary
Q2 sales rose 1.4% to SEK 570 million, with AXXE acquisition contributing 46 MSEK; organic sales dropped 6.8%.
EBIT for Q2 was SEK 28 million (4.9% margin), down from 40 MSEK (7.2%) last year; EBITDA was SEK 29 million, down SEK 12.6 million year-over-year; AXXE contributed SEK 4 million.
Earnings per share were SEK 0.65, impacted by a SEK 4 million currency-related cost.
Cost reduction programs are underway, but effects are delayed due to time lags in implementation.
Cash flow from operations was -3.6 MSEK in Q2, negatively impacted by changes in invoice financing and working capital.
Financial highlights
Last 12 months (LTM) net sales exceeded SEK 2.2 billion, with EBITDA of SEK 157 million (7.1% margin).
Q2 margin was 5% (down from 7.3% last year); Q2 2024 EBITA margin: 5.0%.
H1 2024 net sales: 1,151 MSEK (up from 1,127 MSEK); EBITA: 80.5 MSEK (down from 86.0 MSEK).
Solid equity ratio at 37% (up from 33%); net debt (excl. leasing) at -236 MSEK.
Cash flow from operations for H1: -23.0 MSEK (down from 61.1 MSEK); investments in Q2: 16 MSEK.
Outlook and guidance
Management maintains a SEK 2.4 billion sales target for the year, though acknowledges it is challenging.
EBITDA margin target of 7% is considered achievable even if sales fall short, provided cost cuts are realized.
Book-to-bill ratio has improved since Q4 but remains below one; Q3 is critical for stabilization.
No reliance on M&A to reach 2024 targets; focus is on organic performance, but long-term growth expected through acquisitions.
Project to transfer Enedo's Tunis factory to Inission EMS on track for completion in Q2 2025.
Latest events from Inission
- Sales and margins rose strongly, with robust order intake and a positive outlook.INISS
Q2 2026 - Q1 2026 saw strong sales, margin growth, and robust order intake, signaling market recovery.INISS
Q1 2026 - 2025 revenue rose to SEK 2,206.2 million, with strong cash flow and a positive 2026 outlook.INISS
Q4 2025 - Sales fell 6.2%, but order intake, cash flow, and acquisitions signal H2 recovery.INISS
Q2 2025 - Revised targets and integration efforts position the company for renewed growth next year.INISS
ABGSC Investor Days - Sales and EBIT declined in Q3 2024, with cost cuts and revised targets amid market headwinds.INISS
Q3 2024 - Targeting 15% annual growth and 9% EBITDA margin, leveraging acquisitions and mega trends.INISS
CMD 2025 - Order intake up, but sales and margins fell; cost cuts and Nasdaq listing support cautious optimism.INISS
Q1 & AGM 2025 - Sales and margins fell, but order intake and cash flow rebounded; cost cuts and recovery expected.INISS
Q4 2024